[Federal Register Volume 67, Number 41 (Friday, March 1, 2002)]
[Notices]
[Page 9457]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-5043]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory 
Committee; Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is canceling the 
meeting of the Pediatric Oncology Subcommittee of the Oncologic Drugs 
Advisory Committee scheduled for March 12, 2002. The meeting was 
announced in the Federal Register of February 7, 2002 (67 FR 5831).

FOR FURTHER INFORMATION CONTACT: Thomas H. Perez, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-6758, or FDA Advisory 
Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
Washington, DC area), code 12542.

    Dated: February 26, 2002.
Linda A. Suydam,
Senior Associate Commissioner for Communications and Constituent 
Relations.
[FR Doc. 02-5043 Filed 2-27-02; 11:19 am]
BILLING CODE 4160-01-P